PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Genedata

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Research IT Partnership with Nycomed Expands Genedata's Business Model - Swiss-based drug discovery informatics provider Genedata AG announced today the establishment of a novel research IT alliance with Nycomed, a global leader in innovative pharmaceuticals
Research IT Partnership with Nycomed Expands Genedata's Business Model

 

NewswireToday - /newswire/ - Basel, Switzerland, 2007/11/20 - Swiss-based drug discovery informatics provider Genedata AG announced today the establishment of a novel research IT alliance with Nycomed, a global leader in innovative pharmaceuticals.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

An increasing number of pharmaceutical companies are outsourcing their research IT services to specialized partners in order to increase focus on their core competencies, drive IT innovation and subsequently improve IT performance and reduce overall R&D costs. In line with this trend and Nycomed`s new R&D operating model, Genedata and Nycomed are establishing a strategic partnership that will capitalize on Genedata`s extensive technological expertise to support Nycomed`s proprietary R&D data and knowledge management.

The existing Nycomed research IT infrastructure will be adapted to the new R&D operating model, with Genedata supporting Nycomed in developing and implementing scientific databases and applications for research data management and scientific analysis. The implementation of novel solutions and more efficient workflows is key in this effort. To enhance the smooth integration of Genedata’s expertise into the R&D operations of Nycomed, Genedata has established an office on location, at the Nycomed site in Konstanz, Germany.

“Our new R&D strategy and operating model is aiming for a highly flexible organization that focuses on its core competencies to fill our pipeline with medicines that have true medical utility. For this we were seeking an outsourcing partner able to provide superior technology as well as expertise, and launch quality solutions in a short span of time,“ explained Dr. Karl Zech, Senior Vice President Discovery and Proof of Concept Development at Nycomed. “In addition, effective partnering requires an established, trusting and highly interactive relationship, which makes Genedata a distinguished first choice.”

Dr. Othmar Pfannes, CEO of Genedata AG, said: “We are delighted and committed to take a prolific long-term collaboration to an even higher level, supporting Nycomed to leverage in-house resources and gain competitive advantage. Taking on operational responsibilities represents a new Genedata business approach, that, in complexity and scope, goes beyond the customary provision of software products and services.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Genedata

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Research IT Partnership with Nycomed Expands Genedata's Business Model

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Christiane Becker - Genedata.com 
+41 6169 76099 communications[.]genedata.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Genedata securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Genedata / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)